Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome? (Q89509390)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

review article

1 reference

title

Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

author name string

Yannick Willemen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Maarten Versteven

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Marc Peeters

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Zwi N Berneman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

publication date

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

5 April 2020

copyright license

start time

27 January 2020

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

12 December 2020

A comparison of gene transfer methods in human dendritic cells

1 reference

12 December 2020

Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors

1 reference

12 December 2020

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

12 December 2020

Immunotherapy of cancer with dendritic-cell-based vaccines

1 reference

12 December 2020

Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12

1 reference

12 December 2020

Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

1 reference

12 December 2020

Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication

1 reference

12 December 2020

Induction of Cytotoxic T Lymphocytes With Dendritic Cells Transfected With Human Papillomavirus E6 and E7 RNA: Implications for Cervical Cancer Immunotherapy

1 reference

12 December 2020

Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines

1 reference

12 December 2020

Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer

1 reference

12 December 2020

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

1 reference

12 December 2020

Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product

1 reference

12 December 2020

Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection

1 reference

12 December 2020

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state

1 reference

12 December 2020

The Feasibility and Safety of Immunotherapy with Dendritic Cells Loaded with CEA mRNA Following Neoadjuvant Chemoradiotherapy and Resection of Pancreatic Cancer

1 reference

12 December 2020

Synergy between tumor immunotherapy and antiangiogenic therapy

1 reference

12 December 2020

Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells

1 reference

12 December 2020

Immunotherapy with Autologous, Human Dendritic Cells Transfected with Carcinoembryonic Antigen mRNA

1 reference

12 December 2020

Cancer immunotherapy using RNA-loaded dendritic cells.

1 reference

12 December 2020

Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer.

1 reference

12 December 2020

Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.

1 reference

12 December 2020

Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation

1 reference

12 December 2020

Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.

1 reference

12 December 2020

Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand.

1 reference

12 December 2020

Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.

1 reference

12 December 2020

Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma

1 reference

12 December 2020

Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer

1 reference

12 December 2020

Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life

1 reference

12 December 2020

Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy

1 reference

12 December 2020

Delivery of dendritic cells engineered to secrete IFN-alpha into central nervous system tumors enhances the efficacy of peripheral tumor cell vaccines: dependence on apoptotic pathways

1 reference

12 December 2020

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

1 reference

12 December 2020

An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells

1 reference

12 December 2020

Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12.

1 reference

12 December 2020

Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.

1 reference

12 December 2020

Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.

1 reference

12 December 2020

Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

1 reference

12 December 2020

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells

1 reference

12 December 2020

Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.

1 reference

12 December 2020

Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells.

1 reference

12 December 2020

Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma

1 reference

12 December 2020

Vaccination against the Forkhead Family Transcription Factor Foxp3 Enhances Tumor Immunity

1 reference

12 December 2020

Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments.

1 reference

12 December 2020

Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.

1 reference

12 December 2020

Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes

1 reference

12 December 2020

mRNA-based gene transfer as a tool for gene and cell therapy.

1 reference

12 December 2020

Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity

1 reference

12 December 2020

Tumor vaccine therapy against recrudescent tumor using dendritic cells simultaneously transfected with tumor RNA and granulocyte macrophage colony-stimulating factor RNA.

1 reference

12 December 2020

Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells

1 reference

12 December 2020

Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA

1 reference

12 December 2020

Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells.

1 reference

12 December 2020

Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA

1 reference

12 December 2020

Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.

1 reference

12 December 2020

Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy

1 reference

12 December 2020

Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells.

1 reference

12 December 2020

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

12 December 2020

Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation

1 reference

12 December 2020

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

1 reference

12 December 2020

Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients

1 reference

12 December 2020

Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo

1 reference

12 December 2020

Preoperative Sentinel Node Identification With Ultrasound Using Microbubbles in Patients With Breast Cancer

1 reference

12 December 2020

Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics

1 reference

12 December 2020

hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes

1 reference

12 December 2020

Hallmarks of Cancer: The Next Generation

1 reference

12 December 2020

The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responses

1 reference

12 December 2020

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

1 reference

12 December 2020

An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma.

1 reference

12 December 2020

Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32

1 reference

12 December 2020

Delivery of functional DNA and messenger RNA to mammalian phagocytic cells by recombinant yeast

1 reference

12 December 2020

mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells

1 reference

12 December 2020

Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity

1 reference

12 December 2020

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.

1 reference

12 December 2020

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

1 reference

12 December 2020

Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokines

1 reference

12 December 2020

Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

1 reference

12 December 2020

Cancer immunotherapy via dendritic cells

1 reference

12 December 2020

Dendritic cell-specific transcript: dendritic cell marker and regulator of TLR-induced cytokine production.

1 reference

12 December 2020

Multifunctional triblock copolymers for intracellular messenger RNA delivery

1 reference

12 December 2020

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients

1 reference

12 December 2020

In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer

1 reference

12 December 2020

Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation

1 reference

12 December 2020

Dendritic cells with CED-3 and CED-4 siRNA is effective in prolonging DC lifetime and suppresses tumor growth in gastric cancer

1 reference

12 December 2020

mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.

1 reference

12 December 2020

Cell engineering with synthetic messenger RNA.

1 reference

12 December 2020

mRNA delivery to human dendritic cells by recombinant yeast and activation of antigen-specific memory T cells

1 reference

12 December 2020

Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients

1 reference

12 December 2020

Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients

1 reference

12 December 2020

A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients

1 reference

12 December 2020

Melanoma immunotherapy using mature DCs expressing the constitutive proteasome.

1 reference

12 December 2020

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.

1 reference

12 December 2020

CD8(+) T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC?

1 reference

12 December 2020

Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial

1 reference

12 December 2020

A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading

1 reference

12 December 2020

MicroRNAs and dendritic cell-based vaccination in melanoma patients

1 reference

12 December 2020

Clinical use of dendritic cells for cancer therapy.

1 reference

12 December 2020

Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer

1 reference

12 December 2020

The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy

1 reference

12 December 2020

Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide

1 reference

12 December 2020

Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases

1 reference

12 December 2020

Comparison of cytotoxic T lymphocyte responses against pancreatic cancer induced by dendritic cells transfected with total tumor RNA and fusion hybrided with tumor cell

1 reference

12 December 2020

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

1 reference

12 December 2020

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.

1 reference

12 December 2020

Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results

1 reference

12 December 2020

Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial

1 reference

12 December 2020

Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.

1 reference

12 December 2020

Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma

1 reference

12 December 2020

Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial

1 reference

12 December 2020

Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.

1 reference

12 December 2020

Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

1 reference

12 December 2020

Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma

1 reference

12 December 2020

Use of Cell-Penetrating Peptides in Dendritic Cell-Based Vaccination

1 reference

12 December 2020

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

1 reference

12 December 2020

Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine

1 reference

12 December 2020

mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma.

1 reference

12 December 2020

Chronic Myelocytic Leukemia (CML) Patient-Derived Dendritic Cells Transfected with Autologous Total RNA Induces CML-Specific Cytotoxicity

1 reference

12 December 2020

Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells

1 reference

12 December 2020

Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study.

1 reference

12 December 2020

Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination

1 reference

12 December 2020

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

1 reference

12 December 2020

Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.

1 reference

12 December 2020

Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection

1 reference

12 December 2020

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

1 reference

12 December 2020

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

1 reference

12 December 2020

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

1 reference

12 December 2020

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

1 reference

12 December 2020

Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments.

1 reference

12 December 2020

Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer.

1 reference

12 December 2020

The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy

1 reference

12 December 2020

Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results

1 reference

12 December 2020

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three

1 reference

12 December 2020

Identifiers

DOI

10.3390/CANCERS12020299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32012714%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

PubMed publication ID

32012714

1 reference